Publication details

DEVELOPMENT SAFETY UPDATE REPORT REMED 19. 1. 2023 – 23. 2. 2023

Authors

DEMLOVÁ Regina GRODOVÁ Karolína MALÁSKA Jan

Year of publication 2023
MU Faculty or unit

Faculty of Medicine

Web REMED
Description REMED is national, multicentre clinical trial carried out by the University Hospital Brno in cooperation with RI CZECRIN. The primary objective of the study is to test the hypothesis that administration of dexamethasone 20 mg daily is more effective with COVID-19 compared to a daily dose of dexamethasone 6 mg in adult patients with moderate or severe ARDS. During year 2021 was eight newsletters prepared and sent to clinical sites.

You are running an old browser version. We recommend updating your browser to its latest version.

More info